Development and characterization of the novel human osteosarcoma cell line COS-33 with sustained activation of the mTOR pathway

Outcomes have not improved for metastatic osteosarcoma for several decades. In part, this failure to develop better therapies stems from a lack of understanding of osteosarcoma biology, given the rarity of the disease and the high genetic heterogeneity at the time of diagnosis. We report here the su...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: VanCleave, Ashley, Palmer, Mykayla, Fang, Fang, Torres, Haydee, Rodezno, Tania, Li, Qilin, Fuglsby, Kirby, Evans, Claire, Afeworki, Yohannes, Ross, Alan, Rao, Pulivarthi, Leiferman, Patricia, Zheng, Siyuan, Houghton, Peter, Tao, Jianning
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2020
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7343631/
https://ncbi.nlm.nih.gov/pubmed/32676162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27611
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados